[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Universal Biosensors Inc (UBI.AX)

Universal Biosensors Inc (UBI.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Universal Biosensors Inc 1 Corporate Avenue Rowville VIC 3178 AUS

https://www.universalbiosensors.com P: +61 392139000 F: +61 392139099

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Universal Biosensors Inc is a biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food, and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride, and Xprecia Prime, which are medical devices; Sentia non-medical wine testing products, and Petrackr, which is a blood glucose test used in cats and dogs. It has one reportable segment: a specialist biosensors company. Geographically, the company generates the majority of its revenue from Australia and rest from Americas, Europe and other markets.

Key Statistics

Overview:

Market Capitalization, $K 4,173
Shares Outstanding, K 298,067
% of Institutional Shareholders 0.09%

Financials:

Annual Sales, $ 6,283 K
Annual Net Income, $ -14,240 K
Last Quarter Sales, $ 1,209 K
Last Quarter Net Income, $ -6,611 K

Growth:

1-Year Return -90.00%
3-Year Return -95.17%
5-Year Return -95.69%
5-Year Revenue Growth -1.85%

Per-Share Information:

Most Recent Earnings -0.02 on 08/04/25
Next Earnings Date N/A
Earnings Per Share ttm -0.06
Dividend Payout Ratio 0.00%

UBI.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -110.97%
Return-on-Assets % -72.76%
Profit Margin % -226.65%
Debt/Equity 0.14
Price/Sales 0.70
Price/Book 0.59
Book Value/Share 0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.